ARK Genomic Revolution ETF vs Lithium Americas Corp — how do they compare? ARK Genomic Revolution ETF trades at $44.77, while Lithium Americas Corp trades at $3.27 (market cap $1.18B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | LAC | |
|---|---|---|
Sector | Sector/Thematic | Basic Materials |
52-Week High | $44.55 | $10.05 |
52-Week Low | $24.02 | $2.71 |
Market Cap | — | $1.18B |
Enterprise Value | — | $1.29B |
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →